A case of disseminated strongyloidiasis after multiple courses of immunosuppression

J Mah, A Lieu, E Holmes, S Vaughan - CMAJ, 2022 - Can Med Assoc
• Risk factors for hyperinfection, which is associated with a high risk of death, include use of
immunosuppressant drugs (particularly corticosteroids), human T-cell leukemia virus type 1 …

Overwhelming strongyloidiasis: an unappreciated opportunistic infection

EB SCOWDEN, W SCHAFFNER, WJ STONE - Medicine, 1978 - journals.lww.com
Strongyloides stercoralis is an intestinal nematode which infects a large portion of the
world's population (4, 33). Although precise data are not available, a recent survey …

Disseminated strongyloidiasis: a retrospective study of clinical course and outcome

CS Lam, MKH Tong, KM Chan, YP Siu - European Journal of Clinical …, 2006 - Springer
A retrospective study was carried out to evaluate the clinical course and outcome of
disseminated strongyloidiasis treated in a regional hospital in Hong Kong over a 10-year …

[HTML][HTML] Severe strongyloidiasis with negative serology after corticosteroid treatment

EA Rodriguez, T Abraham… - The American journal of …, 2015 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Strongyloidiasis usually presents as a
chronic and limited disease, but in some immunocompromised patients it may become a life …

A case of persistent strongyloides infection in the immunocompromised patient: failure of standard therapy

AE Petersen, L Tilluckdharry, P Ravichandran… - Chest, 2006 - journal.chestnet.org
INTRODUCTION: Strongyloidiasis is an intestinal nematode infection caused by
Strongyloides stercoralis. The prevalence of S. stercoralis is higher in HTLV-1 positive …

A fatal case of systemic strongyloidiasis and review of the literature

LH Hagelskjaer - European Journal of Clinical Microbiology and …, 1994 - Springer
Systemic strongyloidiasis is a rare but serious complication of intestinal strongyloidiasis. The
condition occurs mainly in immunosuppressed patients and has a significant mortality rate. A …

Disseminated and Hyperinfection Fatal Strongyloidiasis in Two Patients on Immunosuppressive Therapy: A Case Report.

AR Meamar, N Jalallou, L Masoori… - Medical Laboratory …, 2019 - search.ebscohost.com
Abstract Background and Objective: Strongyloides infection is usually asymptomatic in
healthy individuals; however, immunocompromised patients are subject to potential …

Strongyloidiasis in immunosuppressed patients

LH Boram, KF Keller, DE Justus… - American Journal of …, 1981 - academic.oup.com
An increasing number of severe, even fatal cases of strongyloidiasis in patients on
immunosuppressive drugs are being reported. During a 26 month period, three severe …

Disseminated strongyloidiasis in a child with lymphoblastic lymphoma

JD Daubenton, HA Buys, PS Hartley - Journal of pediatric …, 1998 - journals.lww.com
Purpose: This report describes a case of disseminated strongyloidiasis in a child receiving
chemotherapy for T-cell lymphoblastic lymphoma. Patient and Methods: A 10-year-old boy …

Fatal" overwhelming" strongyloidiasis in an immunosuppressed patient

V Bozikov, S Dzebro, K Seidl, M Dominis… - Lijecnicki …, 1996 - europepmc.org
The increased use of immunosuppressants in the treatment of malignant and non-malignant
diseases in today's medicine has significantly contributed to the increased interest in …